Cover Image

Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer

Resistance to targeted drugs is now a challenging clinical problem in the treatment of non-small cell lung cancer (NSCLC). So far, there are no approved targeted therapeutic drugs for patients with disease progression after the third-generation epidermal growth factor receptor-tyrosine kinase inhibi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hang Li (Author), Gulizeba Muhetaer (Author), Yizi Xie (Author), Kainan Yao (Author), Qianqian Ma (Author), Huiting Guan (Author), Sizhong Xing (Author), Xiufang Huang (Author), Jihong Zhou (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis
by: Mario A. Moscarello, et al.
Published: (2013)

Implications of Peptidyl Arginine Deiminase 4 gene transcription and polymorphisms in susceptibility to rheumatoid arthritis in an Iranian population
by: Zahra Bagheri-Hosseinabadi, et al.
Published: (2023)

Inhibition of Peptidyl Arginine Deiminase-4 Prevents Renal Ischemia-Reperfusion-Induced Remote Lung Injury
by: Mingjun Du, et al.
Published: (2020)

Pegylated Arginine Deiminase Downregulates Colitis in Murine Models
by: Helieh S. Oz, et al.
Published: (2012)

Caries-free subjects have high levels of urease and arginine deiminase activity
by: Evelyn REYES, et al.
Published: (2014)

Protein arginine deiminase 2 (PAD2) modulates the polarization of THP-1 macrophages to the anti-inflammatory M2 phenotype
by: Aneta Stachowicz, et al.
Published: (2022)

Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies
by: Tiziano Tuccinardi, et al.
Published: (2019)

Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase
by: Dres Damgaard, et al.
Published: (2017)

Actividad y efectos de ureasa y arginina deiminasa en saliva y biopelícula oral humana Activity and effects of urease and arginine deiminase in saliva and oral human biofilm
by: Évelyn Reyes Beltrán, et al.
Published: (2012)

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance
by: Qingli Cui, et al.
Published: (2022)

Scale-up synthesis of TAP7f, an antitumoral triazolyl peptidyl penicillin
by: Patricia Griselda Cornier
Published: (2020)

Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials
by: Yizi Wang, et al.
Published: (2022)

Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase
by: Xida Zhao, et al.
Published: (2021)

M2e-Derived Peptidyl and Peptide Amphiphile Micelles as Novel Influenza Vaccines
by: Megan C. Schulte, et al.
Published: (2024)

Recent Developments in Peptidyl Diaryl Phoshonates as Inhibitors and Activity-Based Probes for Serine Proteases
by: Marta Maślanka, et al.
Published: (2019)

Osimertinib-associated ashy dermatosis-like hyperpigmentation
by: Pattamon Lertpichitkul, MD, et al.
Published: (2020)

Landscape and significance of human super enhancer-driven core transcription regulatory circuitry
by: Chenchen Feng, et al.
Published: (2023)

A Peptidylic Inhibitor for Neutralizing r(GGGGCC)exp-Associated Neurodegeneration in C9ALS-FTD
by: Qian Zhang, et al.
Published: (2019)

The molecular mechanisms of peptidyl-prolyl cis/trans isomerase Pin1 and its relevance to kidney disease
by: Shukun Wu, et al.
Published: (2024)

Standardization of enzyme-linked immunosorbent assay to detect anti- Porphyromonas gingivalis-peptidylarginine-deiminase antibodies
by: Juliana Cristina Carlos, et al.
Published: (2018)

Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis
by: Songfei Han, et al.
Published: (2023)

Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials
by: Yizi Wang, et al.
Published: (2021)

Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2
by: Wenjiang Zheng, et al.
Published: (2021)

Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
by: Zuqing Su, et al.
Published: (2019)

Rational repurposing, synthesis, in vitro and in silico studies of chromone-peptidyl hybrids as potential agents against Leishmania donovani
by: Ahmed H. E. Hassan, et al.
Published: (2023)

Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery
by: Vejlstrup A, et al.
Published: (2019)

Corrigendum to "Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis" [Pharmacol. Res. 188 (2023) 106668]
by: Tianyao Lei, et al.
Published: (2023)

Drug-induced subacute cutaneous lupus erythematosus involving osimertinib
by: Christian L. Bailey-Burke, AB, et al.
Published: (2024)

Peptidylarginine deiminase (PAD) is a mouse cortical granule protein that plays a role in preimplantation embryonic development
by: Yamada Michiyuki, et al.
Published: (2005)

Instability Mechanism of Osimertinib in Plasma and a Solving Strategy in the Pharmacokinetics Study
by: Zheng Yuan, et al.
Published: (2022)

Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review
by: Xiaofei Gu, et al.
Published: (2024)

Super-sensitive bifunctional nanoprobe: Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy
by: Han Xiao, et al.
Published: (2022)

Osimertinib-associated erythema dyschromicum perstans-like eruption: A case series
by: Christina S. Oh, BA, et al.
Published: (2023)

Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila
by: Qian Zhang, et al.
Published: (2016)

Editorial: Pharmacology of L-Arginine and L-Arginine-Rich Food
by: Burkhard Poeggeler, et al.
Published: (2021)

Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review
by: Feng Wang, et al.
Published: (2022)

Development of Liposomal Vesicles for Osimertinib Delivery to EGFR Mutation-Positive Lung Cancer Cells
by: Paulina Skupin-Mrugalska, et al.
Published: (2020)

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
by: Thomas Rodier, et al.
Published: (2022)

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma
by: Liping Qin, et al.
Published: (2024)

Association Assessment of Peptidylarginine Deiminase Type 4 (PADI4) rs1748033 polymorphism and susceptibility to rheumatoid arthritis in Gorgan, Northeast of Iran
by: Aytekin Aghchelli, et al.
Published: (2018)